Aescap Venture

Aescap Venture is a venture capital firm specializing in investments in seed, expansion, and early stage. It seeks to invest in life sciences ventures and medical companies that focus on the treatment of human diseases using genomics and proteomics, individualized treatment through gene expression profiling, next generation antibody therapeutics, stem-cell based therapies, and gene delivery techniques for vaccines and gene therapies technologies. Within life sciences, the firm invests in biotech, medical technology and healthcare sectors. It typically invests in private companies based in Europe. The firm seeks to invest between €500,000 ($710,000) and €5 million ($7.10 million). It prefers to exit its investments between three years and seven years. The firm co-invests in subsequent rounds of funding. Aescap Venture was founded in 2006 and is based in Amsterdam, Netherlands.